Influences of normobaric hypoxia training on metabolic risk markers in human subjects

Medicine and Science in Sports and Exercise

Volumn 40, Issue 11, 2008, Pages 1939-1944

  Haufe, Sven ^a   Wiesner, Susanne ^a   Engeli, Stefan ^a,b   Luft, Friedrich C ^a   Jordan, Jens ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Adipokines; Body fat amss; Endurance performance; Glucose tolerance

Indexed keywords

ADIPOCYTOKINE; GLUCOSE; INSULIN; LACTIC ACID; LIPID; TRIACYLGLYCEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY FAT; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; ENDURANCE; EXERCISE; EXERCISE TEST; GLUCOSE METABOLISM; HEART RATE; HUMAN; HUMAN EXPERIMENT; HYPOXIA; LIPID METABOLISM; MALE; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; OXYGEN CONSUMPTION; REGULATORY MECHANISM; RESPIRATORY QUOTIENT; RISK FACTOR; TRAINING; VENOUS BLOOD; WORKLOAD;

ADAPTATION, PHYSIOLOGICAL; ADIPOKINES; ADULT; ANOXIA; GLUCOSE TOLERANCE TEST; HUMANS; MALE; METABOLISM; OXYGEN; PHYSICAL EXERTION; PHYSICAL FITNESS; RISK FACTORS; SINGLE-BLIND METHOD; YOUNG ADULT;

EID: 66949154361     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e31817f1988     Document Type: Article

References (35)

1. Achten J, Venables MC, Jeukendrup AE. Fat oxidation rates are higher during running compared with cycling over a wide range of intensities. Metabolism. 2003;52(6):747-52.
2. Ameln H, Gustafsson T, Sundberg CJ, et al. Physiological activation of hypoxia inducible factor-1 in human skeletal muscle. FASEB J. 2005;19(8):1009-11.
3. Ballard TP, Fafara L, Vukovich MD. Comparison of Bod Pod and DXA in female collegiate athletes. Med Sci Sports Exerc. 2004; 36(4):731-5.
4. Bernardi L. Interval hypoxic training. Adv Exp Med Biol. 2001; 502:377-99.
5. Blomstrand E, Radegran G, Saltin B. Maximum rate of oxygen uptake by human skeletal muscle in relation to maximal activities of enzymes in the Krebs cycle. J Physiol. 1997;501(Pt 2):455-60.
6. Carter H, Jones AM, Barstow TJ, Burnley M, Williams CA, Doust JH. Oxygen uptake kinetics in treadmill running and cycle ergometry: a comparison. J Appl Physiol. 2000;89(3):899-907.
7. Dill RP, Chadan SG, Li C, Parkhouse WS. Aging and glucose transporter plasticity in response to hypobaric hypoxia. Mech Ageing Dev. 2001;122(6):533-45.
8. Engfred K, Kjaer M, Secher NH, et al. Hypoxia and training-induced adaptation of hormonal responses to exercise in humans. Eur J Appl Physiol Occup Physiol. 1994;68(4):303-9.
9. Ferezou J, Richalet JP, Coste T, Rathat C. Changes in plasma lipids and lipoprotein cholesterol during a high altitude mountaineering expedition (4800 m). Eur J Appl Physiol Occup Physiol. 1988;57(6):740-5.
10. Fields DA, Goran MI, McCrory MA. Body-composition assessment via air-displacement plethysmography in adults and children: a review. Am J Clin Nutr. 2002;75(3):453-67.
11. Geiser J, Vogt M, Billeter R, Zuleger C, Belforti F, Hoppeler H. Training high-living low: changes of aerobic performance and muscle structure with training at simulated altitude. Int J Sports Med. 2001;22(8):579-85.
12. Gilde AJ, Van BM. Peroxisome proliferator-activated receptors (PPARs): regulators of gene expression in heart and skeletal muscle. Acta Physiol Scand. 2003;178(4):425-34.
13. Gomez-Ambrosi J, Fruhbeck G. Evidence for the involvement of resistin in inflammation and cardiovascular disease. Curr Diabetes Rev. 2005;1(3):227-34.
14. Hoppeler H, Vogt M, Weibel ER, Fluck M. Response of skeletal muscle mitochondria to hypoxia. Exp Physiol. 2003;88(1):109-19.
15. Jakicic JM, Clark K, Coleman E, et al. American College of Sports Medicine position stand. Appropriate intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc. 2001;33(12):2145-56.
16. Kovacs P, Geyer M, Berndt J, et al. Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression. Diabetes. 2007;56(12):3095-100.
17. Kuo CC, Fattor JA, Henderson GC, Brooks GA. Lipid oxidation in fit young adults during postexercise recovery. J Appl Physiol. 2005;99(1):349-56.
18. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science. 2005;307(5708):384-7.
19. Melissa L, MacDougall JD, Tarnopolsky MA, Cipriano N, Green HJ. Skeletal muscle adaptations to training under normobaric hypoxic versus normoxic conditions. Med Sci Sports Exerc. 1997; 29(2):238-43.
20. Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, Ray CA. American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc. 2004;36(3): 533-53.
21. Schrauwen P, Hesselink MK. Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes. 2004;53(6): 1412-7.
22. Semenza GL. Regulation of mammalian O2 homeostasis by hypoxiainducible factor 1. Annu Rev Cell Dev Biol. 1999;15:551-78.
23. Sharma S. Clinical, biochemical, electrocardiographic and non-invasive hemodynamic assessment of cardiovascular status in natives at high to extreme altitudes (3000 m-5500 m) of the Himalayan region. Indian Heart J. 1990;42(5):375-9.
24. Sun G, French CR, Martin GR, et al. Comparison of multi-frequency bioelectrical impedance analysis with dual-energy x-ray absorptiometry for assessment of percentage body fat in a large, healthy population. Am J Clin Nutr. 2005;81(1):74-8.
25. Terrados N, Melichna J, Sylven C, Jansson E, Kaijser L. Effects of training at simulated altitude on performance and muscle metabolic capacity in competitive road cyclists. Eur J Appl Physiol Occup Physiol. 1988;57(2):203-9.
26. Tonkonogi M, Harris B, Sahlin K. Mitochondrial oxidative function in human saponin-skinned muscle fibres: effects of prolonged exercise. J Physiol. 1998;510(Pt 1):279-86.
27. Trujillo ME, Scherer PE. Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med. 2005;257(2):167-75.
28. Trujillo ME, Scherer PE. Adipose tissue-derived factors: impact on health and disease. Endocr Rev. 2006;27(7):762-78.
29. Vogt M, Puntschart A, Geiser J, Zuleger C, Billeter R, Hoppeler H. Molecular adaptations in human skeletal muscle to endurance training under simulated hypoxic conditions. J Appl Physiol. 2001;91(1):173-82.
30. Voors AW, Johnson WD. Altitude and arteriosclerotic heart disease mortality in white residents of 99 of the 100 largest cities in the United States. J Chronic Dis. 1979;32(1-2):157-62.
31. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487-95.
32. Wenger RH. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J. 2002;16(10):1151-62.
33. Winder WW, Taylor EB, Thomson DM. Role of AMP-activated protein kinase in the molecular adaptation to endurance exercise. Med Sci Sports Exerc. 2006;38(11):1945-9.
34. Zoll J, Koulmann N, Bahi L, Ventura-Clapier R, Bigard AX. Quantitative and qualitative adaptation of skeletal muscle mitochondria to increased physical activity. J Cell Physiol. 2003; 194(2):186-93.
35. Zoll J, Ponsot E, Dufour S, et al. Exercise training in normo-baric hypoxia in endurance runners. III. Muscular adjustments of selected gene transcripts. J Appl Physiol. 2006;100(4):1258-66.